Over a decade ago, nanotechnology-based cancer drugs entered clinical trials, such as the albumin-bound paclitaxel nanoparticle used to treat metastatic breast cancer, which showed better efficacy and safety than solvent-formulated paclitaxel (96). Here, ALB is linked to cancer.